Clinical course of pharyngotonsillitis with group A streptococcus treated with different penicillin V strategies, divided in groups of Centor Score 3 and 4: a prospective study in primary care

Table 3 Clinical course after completed PcV treatment for the 420 patients divided into groups based on Centor Score (3 or 4) and given treatment (Penicillin V 800 mg × 4 for 5 days or Penicillin V 1 g × 3 for 10 days)

	3-CS 1 g × 3, 10 days n = 104	3-CS 800 mg × 4, 5 days n = 104	p	4-CS 1 g × 3, 10 days n = 105	4-CS 800 mg × 4, 5 days n = 107	p
Patients with new sore throat related illness^a n (%)	3 (3)	8 (8)	0.19	3 (3)	7 (7)	0.17
Days to recurrence of sore throat-related illness^a (median)	1	1.5	0.82	1	2	0.12
Duration of the sore throat- related illness^a (median)	2	3	0.81	3	3	0.39
Bacterial eradication at follow-up visit n (%)	84 (81)	78 (75)	0.03	81 (77)	82 (77)	0.29
New acute pharyngotonsillitis within one month n (%)	5 (5)	10 (10)	0.20	6 (6)	13 (12)	0.10

ISSN: 1471-2334